Immix Biopharma Statistics

Total Valuation

Immix Biopharma has a market cap or net worth of $66.07 million. The enterprise value is $51.21 million.

Market Cap	66.07M
Enterprise Value	51.21M

Important Dates

The next estimated earnings date is Tuesday, June 17, 2025, after market close.

Earnings Date	Jun 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Immix Biopharma has 27.88 million shares outstanding. The number of shares has increased by 51.33% in one year.

Current Share Class	27.88M
Shares Outstanding	27.88M
Shares Change (YoY)	+51.33%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	21.13%
Owned by Institutions (%)	15.43%
Float	18.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.88
P/TBV Ratio	6.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.11.

Current Ratio	1.80
Quick Ratio	1.71
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -112.34% and return on invested capital (ROIC) is -69.10%.

Return on Equity (ROE)	-112.34%
Return on Assets (ROA)	-50.17%
Return on Invested Capital (ROIC)	-69.10%
Return on Capital Employed (ROCE)	-205.65%
Revenue Per Employee	n/a
Profits Per Employee	-$995,091
Employee Count	21
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Immix Biopharma has paid $42,020 in taxes.

Income Tax	42,020
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.94% in the last 52 weeks. The beta is 0.30, so Immix Biopharma's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+13.94%
50-Day Moving Average	1.91
200-Day Moving Average	1.88
Relative Strength Index (RSI)	57.46
Average Volume (20 Days)	502,322

Short Selling Information

The latest short interest is 213,578, so 0.77% of the outstanding shares have been sold short.

Short Interest	213,578
Short Previous Month	221,217
Short % of Shares Out	0.77%
Short % of Float	1.18%
Short Ratio (days to cover)	3.65

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.77M
Pretax Income	-18.18M
Net Income	-20.90M
EBITDA	-21.70M
EBIT	-21.77M
Earnings Per Share (EPS)	-$0.70

Full Income Statement

Balance Sheet

The company has $15.92 million in cash and $1.06 million in debt, giving a net cash position of $14.86 million or $0.53 per share.

Cash & Cash Equivalents	15.92M
Total Debt	1.06M
Net Cash	14.86M
Net Cash Per Share	$0.53
Equity (Book Value)	9.59M
Book Value Per Share	0.34
Working Capital	7.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.45 million and capital expenditures -$943,480, giving a free cash flow of -$13.40 million.

Operating Cash Flow	-12.45M
Capital Expenditures	-943,480
Free Cash Flow	-13.40M
FCF Per Share	-$0.48

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immix Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-51.33%
Shareholder Yield	-51.33%
Earnings Yield	-31.63%
FCF Yield	-20.28%

Analyst Forecast

The average price target for Immix Biopharma is $7.00, which is 195.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	195.36%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1